Boothbay Fund Management »

Eupraxia Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 156k 7.55

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Vivo Capital
Balyasny Asset Management
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Ikarian Capital
Royal Bank of Canada
Ally Bridge Group
Velan Capital Investment Management
Affinity Asset Advisors
Arrowstreet Capital, Limited Partnership
UBS Group
SummitTX Capital
Marshall Wace

View all funds holding Eupraxia Pharmaceuticals